13.02.2013 Views

Faculty

Faculty

Faculty

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Jeffrey S. BORER,M.D<br />

Biographical Sketch<br />

He is the Gladys and Roland Harriman Professor of Cardiovascular Medicine at Weill Cornell Medical<br />

College, where he also is Professor of Radiology and of Cardiothoracic Surgery, both in Cardiovascular<br />

Medicine, and, administratively, chairs the Section of Cardiovascular Pathophysiology and The Howard<br />

Gilman Institute for Valvular Heart Diseases.<br />

He received his undergraduate education at Harvard, his medical degree from Cornell, and his postgraduate<br />

training at the Massachusetts General Hospital and in the Cardiology Branch of the National<br />

Heart, Lung and Blood Institute of the NIH, where he subsequently established the Nuclear Cardiology<br />

service and served as its first Chief. He was a Senior Fulbright Hays Scholar and Glorney-Raisbeck Fellow<br />

in 1974-75 at Guy's Hospital, University of London, in London, England. In 1979, he returned to Cornell.<br />

Dr. Borer is Editor-in-Chief of Cardiology, one of the world's oldest peer-reviewed cardiovascular journals,<br />

and of Advances in Cardiology, and serves on the Editorial Boards of several major peer-reviewed<br />

journals. Since 1977 he has served continually as an Advisor/Consultant to the Cardio-Renal Division of<br />

the U.S.F.D.A., chairing the Cardio-Renal Advisory Committee for 3 separate terms, the last ending in<br />

2004. He has authored a book on regulatory aspects of cardiovascular drug development and consults<br />

regularly for the pharmaceutical and devices industries. From 1984 through 2005 he served continually as<br />

an Advisor to NASA. He was President of the New York Cardiological Society in 1990-91, President of the<br />

New York State Chapter of the American College of Cardiology from 1997 to 1999, member of the Board<br />

of Governors of the American College of Cardiology from 1997-2000, member of Board of Governors of<br />

the Society of Cardiac Angiography and Interventions from 1995 to 2000, and member of the Board of<br />

Trustees of the Certification Board of Nuclear Cardiology from 1996 to 2002. Currently, he is President of<br />

the Heart Valve Society of America. He has authored 4 books and authored or co-authored almost 400<br />

journal articles, reviews and chapters. His research achievements have included (1) establishment of the<br />

benefits of the drug, nitroglycerin, during acute myocardial infarction (1971-75); (2) development of realtime<br />

radionuclide cineangiography and its application during exercise (1976-1979); (3) development of<br />

non-invasive prognostic indices in patients with coronary artery and valvular diseases (1979-present); (4)<br />

exploration of the cellular and molecular bases of heart failure in regurgitant valvular diseases and other<br />

volume overload states (1984-present). He has received several peer recognitions including the<br />

Hans-Peter Krayenbeuhl Memorial Award of the International Society of Cardiology in 2002 and the Public<br />

Service Medal of the National Aeronautics and Space Administration in 1999.<br />

____________________________________________________________________________<br />

Jan BUCH<br />

1969 MD Copenhagen University. Denmark<br />

1969 ECFMG Exam (Educational Council for Foreign Medical Graduates).<br />

USA<br />

Specialist in internal medicine and cardiology from Copenhagen University<br />

1969-1987 Employed at various university hospitals in Copenhagen. Denmark<br />

- 10-11 years at the main cardiological service at the university, Rigshospitalet<br />

(including 6 years in invasive cardiology<br />

1987-1991 Medical Director. Pfizer, Denmark<br />

1992-1999 Senior Associate Medical Director. Norvasc Team, Pfizer International, HQ, New York<br />

1999-2001 Medical Director. Norvasc Team, Pfizer Pharmaceuticals Group<br />

2001-2003 Senior Medical Director. Norvasc Team, Pfizer Pharmaceuticals Group<br />

2003-2006 Senior Medical Director, Caduet/Norvasc Team, Pfizer Global Pharmaceuticals<br />

2006 Senior Medical Director/World Wide Team Leader - Cardiovascular, Metabolic and<br />

Endocrine. Pfizer Global Pharmaceuticals<br />

2007 Global Team Leader/Senior Medical Director - Global CVM Medical<br />

Group. Medical Division, Pfizer Inc

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!